"You are correct in they do need capital, and they themselves have stated it". Would you please point where they said this recently.
The last Qtr showed an N/A for number of quarters of funding on hand. This means they had net inflows over the quarter in the runup to the P2 start.
They also had $8.4m in cash as at 31Dec and are quite clearly well funded through well into the Phase2.
But you are right that the next raise will be with $1+.
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007, page-24
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.5¢ |
Change
-0.015(2.08%) |
Mkt cap ! $86.58M | |||
| Open | High | Low | Value | Volume |
| 72.0¢ | 72.0¢ | 70.0¢ | $55.25K | 77.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 16703 | 69.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 71.0¢ | 9898 | 2 |
View Market Depth
| Last trade - 14.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
69.5¢ |
Change
-0.015 ( 2.80 %) |
||||
| Open | High | Low | Volume | ||
| 70.0¢ | 70.0¢ | 69.5¢ | 5477 | ||
| Last updated 13.58pm 24/05/2024 ? | |||||
| AGN (ASX) Chart |